326 related articles for article (PubMed ID: 16973364)
21. Efficacy of three potent steroid sulfatase inhibitors: pre-clinical investigations for their use in the treatment of hormone-dependent breast cancer.
Foster PA; Chander SK; Parsons MF; Newman SP; Woo LW; Potter BV; Reed MJ; Purohit A
Breast Cancer Res Treat; 2008 Sep; 111(1):129-38. PubMed ID: 17914670
[TBL] [Abstract][Full Text] [Related]
22. 2-difluoromethyloestrone 3-O-sulphamate, a highly potent steroid sulphatase inhibitor.
Reed JE; Woo LW; Robinson JJ; Leblond B; Leese MP; Purohit A; Reed MJ; Potter BV
Biochem Biophys Res Commun; 2004 Apr; 317(1):169-75. PubMed ID: 15047163
[TBL] [Abstract][Full Text] [Related]
23. Synthesis, in vitro and in vivo activity of benzophenone-based inhibitors of steroid sulfatase.
Hejaz HA; Woo LW; Purohit A; Reed MJ; Potter BV
Bioorg Med Chem; 2004 May; 12(10):2759-72. PubMed ID: 15110857
[TBL] [Abstract][Full Text] [Related]
24. Inactivation of recombinant human steroid sulfatase by KW-2581.
Ishida H; Sato N; Hosogi J; Tanaka H; Kuwabara T
J Steroid Biochem Mol Biol; 2008 Jan; 108(1-2):17-22. PubMed ID: 17945483
[TBL] [Abstract][Full Text] [Related]
25. Estrone sulfatase: probing structural requirements for substrate and inhibitor recognition.
Anderson C; Freeman J; Lucas LH; Farley M; Dalhoumi H; Widlanski TS
Biochemistry; 1997 Mar; 36(9):2586-94. PubMed ID: 9054565
[TBL] [Abstract][Full Text] [Related]
26. 17β-Arylsulfonamides of 17β-aminoestra-1,3,5(10)-trien-3-ol as highly potent inhibitors of steroid sulfatase.
Mostafa YA; Taylor SD
Bioorg Med Chem; 2012 Feb; 20(4):1535-44. PubMed ID: 22264754
[TBL] [Abstract][Full Text] [Related]
27. Estrogenic potential of 2-alkyl-4-(thio)chromenone 6-O-sulfamates: potent inhibitors of human steroid sulfatase.
Nussbaumer P; Winiski AP; Billich A
J Med Chem; 2003 Nov; 46(23):5091-4. PubMed ID: 14584960
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological activity of the superestrogen (E)-17-oximino-3-O-sulfamoyl-1,3,5(10)-estratriene: x-ray crystal structure of (E)-17-oximino-3-hydroxy-1,3,5(10)-estratriene.
Hejaz HA; Purohit A; Mahon MF; Reed MJ; Potter BV
J Med Chem; 1999 Aug; 42(16):3188-92. PubMed ID: 10447965
[TBL] [Abstract][Full Text] [Related]
29. Chemical synthesis and evaluation of 17α-alkylated derivatives of estradiol as inhibitors of steroid sulfatase.
Fournier D; Poirier D
Eur J Med Chem; 2011 Sep; 46(9):4227-37. PubMed ID: 21782294
[TBL] [Abstract][Full Text] [Related]
30. Potent inhibition of steroid sulfatase activity by 3-O-sulfamate 17alpha-benzyl(or 4'-tert-butylbenzyl)estra-1,3,5(10)-trienes: combination of two substituents at positions C3 and c17alpha of estradiol.
Ciobanu LC; Boivin RP; Luu-The V; Labrie F; Poirier D
J Med Chem; 1999 Jun; 42(12):2280-6. PubMed ID: 10377235
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of estrone sulfate-induced uterine growth by potent nonestrogenic steroidal inhibitors of steroid sulfatase.
Ciobanu LC; Luu-The V; Martel C; Labrie F; Poirier D
Cancer Res; 2003 Oct; 63(19):6442-6. PubMed ID: 14559834
[TBL] [Abstract][Full Text] [Related]
32. 2-phenylindole sulfamates: inhibitors of steroid sulfatase with antiproliferative activity in MCF-7 breast cancer cells.
Walter G; Liebl R; von Angerer E
J Steroid Biochem Mol Biol; 2004 Apr; 88(4-5):409-20. PubMed ID: 15145451
[TBL] [Abstract][Full Text] [Related]
33. Steroid sulfatase: a pivotal player in estrogen synthesis and metabolism.
Purohit A; Woo LW; Potter BV
Mol Cell Endocrinol; 2011 Jul; 340(2):154-60. PubMed ID: 21693170
[TBL] [Abstract][Full Text] [Related]
34. Stimulation of MCF-7 breast cancer cell proliferation by estrone sulfate and dehydroepiandrosterone sulfate: inhibition by novel non-steroidal steroid sulfatase inhibitors.
Billich A; Nussbaumer P; Lehr P
J Steroid Biochem Mol Biol; 2000; 73(5):225-35. PubMed ID: 11070351
[TBL] [Abstract][Full Text] [Related]
35. Design and synthesis of silicon-containing steroid sulfatase inhibitors possessing pro-estrogen antagonistic character.
Kajita D; Nakamura M; Matsumoto Y; Makishima M; Hashimoto Y
Bioorg Med Chem; 2014 Apr; 22(7):2244-52. PubMed ID: 24630694
[TBL] [Abstract][Full Text] [Related]
36. First crystal structures of human carbonic anhydrase II in complex with dual aromatase-steroid sulfatase inhibitors.
Lloyd MD; Thiyagarajan N; Ho YT; Woo LW; Sutcliffe OB; Purohit A; Reed MJ; Acharya KR; Potter BV
Biochemistry; 2005 May; 44(18):6858-66. PubMed ID: 15865431
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of steroid sulfatase activity and cell proliferation in ZR-75-1 and BT-474 human breast cancer cells by KW-2581 in vitro and in vivo.
Ishida H; Nakata T; Sato N; Li PK; Kuwabara T; Akinaga S
Breast Cancer Res Treat; 2007 Aug; 104(2):211-9. PubMed ID: 17061037
[TBL] [Abstract][Full Text] [Related]
38. D-ring modified estrone derivatives as novel potent inhibitors of steroid sulfatase.
Fischer DS; Woo LW; Mahon MF; Purohit A; Reed MJ; Potter BV
Bioorg Med Chem; 2003 Apr; 11(8):1685-700. PubMed ID: 12659755
[TBL] [Abstract][Full Text] [Related]
39. A novel steroidal selective steroid sulfatase inhibitor KW-2581 inhibits sulfated-estrogen dependent growth of breast cancer cells in vitro and in animal models.
Ishida H; Nakata T; Suzuki M; Shiotsu Y; Tanaka H; Sato N; Terasaki Y; Takebayashi M; Anazawa H; Murakata C; Li PK; Kuwabara T; Akinaga S
Breast Cancer Res Treat; 2007 Dec; 106(2):215-27. PubMed ID: 17268815
[TBL] [Abstract][Full Text] [Related]
40. Phase I study of STX 64 (667 Coumate) in breast cancer patients: the first study of a steroid sulfatase inhibitor.
Stanway SJ; Purohit A; Woo LW; Sufi S; Vigushin D; Ward R; Wilson RH; Stanczyk FZ; Dobbs N; Kulinskaya E; Elliott M; Potter BV; Reed MJ; Coombes RC
Clin Cancer Res; 2006 Mar; 12(5):1585-92. PubMed ID: 16533785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
